Transplant; Complication, Failure

3

Review clinical trials related to Transplant; Complication, Failure. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)

Advances in surgical and medical care have led to improved outcomes in patients with congenital heart disease (CHD). As a consequence, the majority of patients nowadays survives to adulthood (adults with CHD, that is, adult CHD \[ACHD\]) with good quality of life. Despite the surgical success, the morbidity and mortality of ACHD is higher than in the general population and is linked to the development of heart failure (HF) in adulthood. HF occurs in approximately 25% of patients with ACHD, even in those patients in whom the congenital mal-formation has been corrected successfully in childhood. The time course and presentation are heterogeneous owing to variable congenital malformation and limitation of treatment options. ACHD with an anatomic right ventricle as the systemic ventricle (e.g., atrial switch operation in patients with transposition of the great arteries \[TGAs\]) and those with a functional single ventricle (e.g., Fontan circulation) appear to be at higher risk of developing HF. Young age at initial corrective surgery-often in the first 2 years of life-and lack of specific medical therapies can contribute to a high and early demand for heart transplantation in patients with ACHD.

Participants needed: 2,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Universitätsklinikum Hamburg-EppendorfUpdated: Jul 1, 2026Locations: 1Duration: 30 Years
Eligibility criteria

The patient has to be listed as an adult transplant candidate in the country the... [+4]

Status: Recruiting

EVEROLD LONG TERM FOLLOW-UP

Long Term Follow up of EVEROLD study

Participants needed: 260
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BrestUpdated: Feb 6, 2025Locations: 14
Eligibility criteria

Informed patients participating to the EVEROLD study [+2]

Opposition to the use his medical data [+1]

Status: Not yet recruiting

Evaluation at 5 and 10 Years of Renal Transplant Patients

5 and 10 years follow-up of the oxyop study.

Participants needed: 116
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BrestUpdated: Jul 22, 2022Locations: 1
Eligibility criteria

informed patients participating to the oxyop study [+2]

Opposition to the use his medical data [+1]